BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 24462862)

  • 1. OX40 ligand regulates splenic CD8⁻ dendritic cell-induced Th2 responses in vivo.
    Kamachi F; Harada N; Usui Y; Sakanishi T; Ishii N; Okumura K; Miyake S; Akiba H
    Biochem Biophys Res Commun; 2014 Feb; 444(2):235-40. PubMed ID: 24462862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential capacity of CD8+ alpha or CD8- alpha dendritic cell subsets to prime for eosinophilic airway inflammation in the T-helper type 2-prone milieu of the lung.
    Hammad H; de Vries VC; Maldonado-Lopez R; Moser M; Maliszewski C; Hoogsteden HC; Lambrecht BN
    Clin Exp Allergy; 2004 Dec; 34(12):1834-40. PubMed ID: 15663556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Splenic dendritic cells pulsed with Ixodes ricinus tick saliva prime naive CD4+T to induce Th2 cell differentiation in vitro and in vivo.
    Mejri N; Brossard M
    Int Immunol; 2007 Apr; 19(4):535-43. PubMed ID: 17344202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. OX40 (CD134) and OX40 ligand interaction plays an adjuvant role during in vivo Th2 responses.
    Ishii N; Ndhlovu LC; Murata K; Sato T; Kamanaka M; Sugamura K
    Eur J Immunol; 2003 Sep; 33(9):2372-81. PubMed ID: 12938213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interruption of the Tnfrsf4/Tnfsf4 (OX40/OX40L) pathway attenuates atherogenesis in low-density lipoprotein receptor-deficient mice.
    van Wanrooij EJ; van Puijvelde GH; de Vos P; Yagita H; van Berkel TJ; Kuiper J
    Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):204-10. PubMed ID: 17068285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ox40 costimulation enhances the development of T cell responses induced by dendritic cells in vivo.
    De Smedt T; Smith J; Baum P; Fanslow W; Butz E; Maliszewski C
    J Immunol; 2002 Jan; 168(2):661-70. PubMed ID: 11777959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastrointestinal dendritic cells promote Th2 skewing via OX40L.
    Blázquez AB; Berin MC
    J Immunol; 2008 Apr; 180(7):4441-50. PubMed ID: 18354165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical role for OX40 ligand in the development of pathogenic Th2 cells in a murine model of asthma.
    Hoshino A; Tanaka Y; Akiba H; Asakura Y; Mita Y; Sakurai T; Takaoka A; Nakaike S; Ishii N; Sugamura K; Yagita H; Okumura K
    Eur J Immunol; 2003 Apr; 33(4):861-9. PubMed ID: 12672051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-12, as an adjuvant, promotes a T helper 1 cell, but does not suppress a T helper 2 cell recall response.
    Bliss J; Van Cleave V; Murray K; Wiencis A; Ketchum M; Maylor R; Haire T; Resmini C; Abbas AK; Wolf SF
    J Immunol; 1996 Feb; 156(3):887-94. PubMed ID: 8558014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of OX40 ligand interactions in the development of the Th2 response to the gastrointestinal nematode parasite Heligmosomoides polygyrus.
    Ekkens MJ; Liu Z; Liu Q; Whitmire J; Xiao S; Foster A; Pesce J; VanNoy J; Sharpe AH; Urban JF; Gause WC
    J Immunol; 2003 Jan; 170(1):384-93. PubMed ID: 12496423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ligation of OX40 (CD134) regulates graft-versus-host disease (GVHD) and graft rejection in allogeneic bone marrow transplant recipients.
    Blazar BR; Sharpe AH; Chen AI; Panoskaltsis-Mortari A; Lees C; Akiba H; Yagita H; Killeen N; Taylor PA
    Blood; 2003 May; 101(9):3741-8. PubMed ID: 12521997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Requirements for the functional expression of OX40 ligand on human activated CD4+ and CD8+ T cells.
    Kondo K; Okuma K; Tanaka R; Zhang LF; Kodama A; Takahashi Y; Yamamoto N; Ansari AA; Tanaka Y
    Hum Immunol; 2007 Jul; 68(7):563-71. PubMed ID: 17584577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ox40L-Ox40 pathway plays distinct roles in regulating Th2 responses but does not determine outcome of cutaneous leishmaniasis caused by Leishmania mexicana and Leishmania major.
    Tuladhar R; Oghumu S; Dong R; Peterson A; Sharpe AH; Satoskar AR
    Exp Parasitol; 2015 Jan; 148():49-55. PubMed ID: 25447125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activated T cells express the OX40 ligand: requirements for induction and costimulatory function.
    Mendel I; Shevach EM
    Immunology; 2006 Feb; 117(2):196-204. PubMed ID: 16423055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early production of IL-4 and induction of Th2 responses in the lymph node originate from an MHC class I-independent CD4+NK1.1- T cell population.
    von der Weid T; Beebe AM; Roopenian DC; Coffman RL
    J Immunol; 1996 Nov; 157(10):4421-7. PubMed ID: 8906817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-33, but not thymic stromal lymphopoietin or IL-25, is central to mite and peanut allergic sensitization.
    Chu DK; Llop-Guevara A; Walker TD; Flader K; Goncharova S; Boudreau JE; Moore CL; Seunghyun In T; Waserman S; Coyle AJ; Kolbeck R; Humbles AA; Jordana M
    J Allergy Clin Immunol; 2013 Jan; 131(1):187-200.e1-8. PubMed ID: 23006545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical contribution of OX40 ligand to T helper cell type 2 differentiation in experimental leishmaniasis.
    Akiba H; Miyahira Y; Atsuta M; Takeda K; Nohara C; Futagawa T; Matsuda H; Aoki T; Yagita H; Okumura K
    J Exp Med; 2000 Jan; 191(2):375-80. PubMed ID: 10637281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protease activity of Per a 10 potentiates Th2 polarization by increasing IL-23 and OX40L.
    Agrawal K; Kale SL; Arora N
    Eur J Immunol; 2015 Dec; 45(12):3375-85. PubMed ID: 26417883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD28-independent costimulation of T cells by OX40 ligand and CD70 on activated B cells.
    Akiba H; Oshima H; Takeda K; Atsuta M; Nakano H; Nakajima A; Nohara C; Yagita H; Okumura K
    J Immunol; 1999 Jun; 162(12):7058-66. PubMed ID: 10358148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of human allergic T-helper type 2 immune responses by induced regulatory T cells requires the combination of interleukin-10-treated dendritic cells and transforming growth factor-beta for their induction.
    Bellinghausen I; König B; Böttcher I; Knop J; Saloga J
    Clin Exp Allergy; 2006 Dec; 36(12):1546-55. PubMed ID: 17177678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.